Effect of N-Acetylcysteine Pretreatment of Deceased Organ Donors on Renal Allograft Function
Authors:
Open Access
- 1 April 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 99 (4) , 746-753
Abstract
Antioxidant donor pretreatment is one of the pharmacologic strategy proposed to prevent renal ischemia-reperfusion injuries and delayed graft function (DGF). The aim of the study was to investigate whether a donor pretreatment with N-acetylcysteine (NAC) reduces the incidence of DGF in adult human kidney transplant recipients. In this randomized, open-label, monocenter trial, 160 deceased heart-beating donors were allowed to perform 236 renal transplantations from September 2005 to December 2010. Donors were randomized to receive, in a single-blind controlled fashion, 600 mg of intravenous NAC 1 hr before and 2 hr after cerebral angiography performed to confirm brain death. Primary endpoint was DGF defined by the need for at least one dialysis session within the first week or a serum creatinine level greater than 200 μmol/L at day 7 after kidney transplantation. The incidence of DGF was similar between donors pretreated with or without NAC (39/118; 33% vs. 30/118; 25.4%; P = 0.19). Requirement for at least one dialysis session was not different between the NAC and No NAC groups (17/118; 14.4% vs. 14/118; 11.8%, P = 0.56). The two groups had comparable serum creatinine levels, estimated glomerular filtration rates, and daily urine output at days 1, 7, 15, and 30 after kidney transplantation as well as at hospital discharge. No difference in recipient mortality nor in 1-year kidney graft survival was observed. Donor pretreatment with NAC does not improve delayed graft function after kidney transplantation.Keywords
This publication has 47 references indexed in Scilit:
- Summary of Recommendation StatementsKidney International Supplements, 2012
- Section 4: Contrast-induced AKIKidney International Supplements, 2012
- Delayed Graft Function in the Kidney TransplantAmerican Journal of Transplantation, 2011
- Impact of High-Dose N-Acetylcysteine Versus Placebo on Contrast-Induced Nephropathy and Myocardial Reperfusion Injury in Unselected Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionJACC, 2010
- Delayed Graft Function and the Risk for Death with a Functioning GraftJournal of the American Society of Nephrology, 2010
- Therapeutic Interventions Favorably Influencing Delayed and Slow Graft Function in Kidney Transplantation: Mission Impossible?Transplantation, 2008
- N-Acetylcysteine in the Prevention of Contrast-Induced NephropathyClinical Journal of the American Society of Nephrology, 2008
- Influence of Donor Pretreatment With N-Acetylcysteine on Ischemia/Reperfusion Injury in Rat Kidney GraftsJournal of Urology, 2004
- Intestinal ischemia and reperfusion injury in growing rats: Hypothermia and N‐acetylcysteine modulationMicrosurgery, 2003
- N-acetylcysteine ameliorates renal microcirculation: Studies in ratsKidney International, 2003